# MiNK Therapeutics (INKT) — Earnings

INKT · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/inkt/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.62 |
| EPS estimate | −$0.60 |
| EPS surprise | −3.33% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 13, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1840229/000119312526349309/inkt-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/cd6e62b3-5a02-ca00-b963-6ee674e892e6.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 13, 2026 | −$0.60 | −$0.62 | -3.33% | — | — |
| Q1 2026 | May 15, 2026 | −$0.77 | −$0.57 | 25.97% | — | — |
| Q4 2025 | Mar 31, 2026 | −$0.68 | −$0.52 | 23.53% | — | — |
| Q3 2025 | Nov 14, 2025 | −$0.86 | −$0.65 | 23.98% | — | — |
| Q2 2025 | Aug 14, 2025 | −$0.55 | −$1.06 | -93.89% | — | — |
| Q1 2025 | May 15, 2025 | −$0.61 | −$0.70 | -15.19% | — | — |
| Q4 2024 | Mar 18, 2025 | −$0.49 | −$0.62 | -27.39% | — | — |
| Q3 2024 | Nov 14, 2024 | −$0.80 | −$0.50 | 37.55% | — | — |
| Q2 2024 | Aug 13, 2024 | −$0.98 | −$0.70 | 28.70% | — | — |
| Q1 2024 | May 14, 2024 | −$1.53 | −$1.10 | 27.87% | — | — |
| Q4 2023 | Mar 21, 2024 | −$1.53 | −$1.60 | -4.92% | — | — |
| Q3 2023 | Nov 9, 2023 | −$1.82 | −$1.50 | 17.39% | — | — |
| Q2 2023 | Aug 10, 2023 | −$1.98 | −$1.80 | 8.86% | — | — |
| Q1 2023 | May 11, 2023 | −$2.38 | −$1.70 | 28.56% | — | — |
| Q4 2022 | Mar 21, 2023 | −$2.10 | −$2.30 | -9.66% | — | — |
| Q3 2022 | Nov 3, 2022 | −$2.26 | −$1.90 | 15.93% | — | — |
| Q2 2022 | Aug 9, 2022 | −$2.33 | −$1.80 | 22.58% | — | — |
| Q1 2022 | May 10, 2022 | −$2.07 | −$2.30 | -11.29% | — | — |
| Q4 2021 | Mar 18, 2022 | −$4.10 | −$1.80 | 56.10% | — | — |

## Frequently Asked Questions

### When did MiNK Therapeutics (INKT) last report earnings?

MiNK Therapeutics last reported on Aug 13, 2026, covering fiscal Q2 2026.

### Did INKT beat earnings estimates?

No. MiNK Therapeutics reported EPS of −$0.62 for Q2 2026 against a −$0.60 estimate — a 3.33% miss.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).